Single-dose liposomal amphotericin B (AmBisome(®)) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial

BACKGROUND: AmBisome(® )is an efficacious, safe anti-leishmanial treatment. There is growing interest in its use, either as a single dose or in combination treatments. In East Africa, the minimum optimal single-dosage has not been identified. METHODS/DESIGN: An open-label, 2-arm, non-inferiority, mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Tansy, Omollo, Raymond, Khalil, Eltahir AG, Yifru, Sisay, Musa, Brima, Musa, Ahmed, Wasunna , Monique, Smith, Peter G, Royce, Catherine, Ellis, Sally, Balasegaram, Manica, Hailu, Asrat
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061925/
https://www.ncbi.nlm.nih.gov/pubmed/21375777
http://dx.doi.org/10.1186/1745-6215-12-66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061925/
https://www.ncbi.nlm.nih.gov/pubmed/21375777
http://dx.doi.org/10.1186/1745-6215-12-66

Ejemplares similares